Australian Clinical Labs Limited News - ACL

UPDATE: River Plate Eye Product Gets Thumbs Down From Panel

A panel of medical experts on Friday said a proposed eyedrop drug by River Plate Biotechnology Inc. isn't safe and effective enough to treat...

River Plate Eye Product Gets Thumbs Down From FDA Panel

A panel of medical experts on Friday said a proposed eyedrop drug by River Plate Biotechnology Inc. isn't safe and effective enough to treat...

UPDATE: FDA: ISTA Eye Drop Effective; Concern On Rejena

The Food and Drug Administration said Wednesday that ISTA Pharmaceutical Inc.'s (ISTA) Bepreve eye drops were effective at treating eye-itching...

FDA: Doctors Must Tell People About Lasik Eye Surgery Risks

Doctors need to give patients detailed information about the risks associated with Lasik eye surgery, the U.S. Food and Drug Administration said...

Abbreviated New Drug Application for Fondaparinux Accepted by US Food and Drug Administration

Australian drug developer, Alchemia Limited (ASX:ACL), today announced that its global manufacturing and U.S. marketing partner...

Novartis CEO: Co Hopes To Buy 52% Alcon Stake From Nestle

Novartis AG (NVS) Chief Executive Daniel Vasella Thursday said the Swiss drugmaker hopes to buy a 52% stake in U.S. eyecare maker Alcon Inc. (ACL...

Novartis: No Changes To Nestle Agreement On Alcon Planned

Swiss drugmaker Novartis AG (NVS) doesn't plan any changes to its agreement with Nestle SA (NESN.VX) on eye-care company Alcon Inc. (ACL...

GlaxoSmithKline CEO: Still Not Interested In Large M&A

GlaxoSmithKline PLC (GSK) is "not in the market" for big merger and acquisition deals, but will continue to look for targeted investments and...

CORRECT(2/19):Nestle 2nd Half Net Jumps;Indicates Will Keep L'Oreal

Nestle SA (NESN.VX) Thursday gave a guarded outlook for 2009 - even though it raised its dividend after reporting a more-than-doubled net profit...

CORRECT(2/19):Nestle Hints Will Keep L'Oreal;No Alcon Terms Change

Nestle S.A. (NESN.VX) will likely keep its large stake in French cosmetics company L'Oreal S.A. (12032.FR) for the time being and doesn't plan to...

Nestle Open For Purchases, No Major Acquisition In Sight

Nestle S.A. (NESN.VX) is open for acquisitions but no major purchase is imminent, company executives said Thursday. "We are open for acquisitions...

UPDATE: Nestle Hints Will Keep L'Oreal; No Alcon Terms Change

Nestle S.A. (NESN.VX) will likely keep its large stake in French cosmetics company L'Oreal S.A. (12032.FR) for the time being and doesn't plan to...

2nd UPDATE: Nestle 2nd Half Net Jumps; Indicates Will Keep L'Oreal

Nestle SA (NESN.VX) Thursday gave a guarded outlook for 2009 - even though it raised its dividend after reporting a more-than-doubled net profit...

UPDATE: Nestle 2nd Half Net More Than Doubles; Tones Down Outlook

Nestle SA (NESN.VX), the world's largest food and beverages company, Thursday gave a guarded outlook for 2009 - even though it raised its dividend...

Nestle Not Pressed On L'Oreal, No Plan To Change Alcon Terms

Nestle S.A. (NESN.VX) is in no hurry to act on its large stake in French cosmetics company L'Oreal S.A. (12032.FR) and doesn't plan to change the...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Australian Clinical Labs Limited (ACL)

Professional-Grade Tools, for Individual Investors.

ACL News

UPDATE: River Plate Eye Product Gets Thumbs Down From Panel

River Plate Eye Product Gets Thumbs Down From FDA Panel

UPDATE: FDA: ISTA Eye Drop Effective; Concern On Rejena

FDA: Doctors Must Tell People About Lasik Eye Surgery Risks

Abbreviated New Drug Application for Fondaparinux Accepted by US Food and Drug Administration

Novartis CEO: Co Hopes To Buy 52% Alcon Stake From Nestle

Novartis: No Changes To Nestle Agreement On Alcon Planned

GlaxoSmithKline CEO: Still Not Interested In Large M&A

CORRECT(2/19):Nestle 2nd Half Net Jumps;Indicates Will Keep L'Oreal

CORRECT(2/19):Nestle Hints Will Keep L'Oreal;No Alcon Terms Change

Nestle Open For Purchases, No Major Acquisition In Sight

UPDATE: Nestle Hints Will Keep L'Oreal; No Alcon Terms Change

2nd UPDATE: Nestle 2nd Half Net Jumps; Indicates Will Keep L'Oreal

UPDATE: Nestle 2nd Half Net More Than Doubles; Tones Down Outlook

Nestle Not Pressed On L'Oreal, No Plan To Change Alcon Terms

ACL Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Australian Clinical Labs Limited (ACL) News

Australian Clinical Labs Limited (ACL)

Professional-Grade Tools, for Individual Investors.

ACL News

UPDATE: River Plate Eye Product Gets Thumbs Down From Panel

River Plate Eye Product Gets Thumbs Down From FDA Panel

UPDATE: FDA: ISTA Eye Drop Effective; Concern On Rejena

FDA: Doctors Must Tell People About Lasik Eye Surgery Risks

Abbreviated New Drug Application for Fondaparinux Accepted by US Food and Drug Administration

Novartis CEO: Co Hopes To Buy 52% Alcon Stake From Nestle

Novartis: No Changes To Nestle Agreement On Alcon Planned

GlaxoSmithKline CEO: Still Not Interested In Large M&A

CORRECT(2/19):Nestle 2nd Half Net Jumps;Indicates Will Keep L'Oreal

CORRECT(2/19):Nestle Hints Will Keep L'Oreal;No Alcon Terms Change

Nestle Open For Purchases, No Major Acquisition In Sight

UPDATE: Nestle Hints Will Keep L'Oreal; No Alcon Terms Change

2nd UPDATE: Nestle 2nd Half Net Jumps; Indicates Will Keep L'Oreal

UPDATE: Nestle 2nd Half Net More Than Doubles; Tones Down Outlook

Nestle Not Pressed On L'Oreal, No Plan To Change Alcon Terms

ACL Discussion

Your Recent History